CAS NO: | 1173021-73-2 |
包装 | 价格(元) |
500μg | 电议 |
1mg | 电议 |
Cas No. | 1173021-73-2 |
别名 | 氘代沙丁醇胺,Albuterol-d9; AH-3365-d9 |
Canonical SMILES | OCC1=C(O)C=CC(C(O)CNC(C([2H])([2H])[2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])=C1 |
分子式 | C13H12D9NO3 |
分子量 | 248.4 |
溶解度 | Methanol: Slightly Soluble,Water: Slightly Soluble |
储存条件 | Store at -20°C |
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
产品描述 | Salbutamol-d9 is intended for use as an internal standard for the quantification of salbutamol by GC- or LC-MS. Salbutamol is an agonist of the β2-adrenergic receptor (β2-AR; Kd = 759 nM in a radioligand binding assay using CHO cells expressing the human receptor).1 It is selective for β2-ARs over β1- and β3-ARs (Kds = 46.8 and 21.9 μM, respectively). Salbutamol (25-50 μg/kg, i.v.) reduces acetylcholine-induced bronchospasm in anesthetized guinea pigs.2 It also reduces response of bronchial muscle to efferent vagal stimulation in anesthetized cats and dogs when administered at doses ranging from 1 to 2.5 and 10 to 20 μg/kg, respectively. Nebulized salbutamol reduces transpulmonary pressure in recurrent airway obstruction-affected horses (EC50 = 39.7 μg).3 Formulations containing salbutamol have been used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). References |